Back to Search
Start Over
I-131-Meta-Iodobenzylguanidine (MIBG) Therapy Improves Survival in High-Risk Neuroblastoma Patients with MIBG Positive Residual Metastatic Disease
- Authors :
- Simon, T.
Schmidt, M.
Decarolis, B.
Eggert, A.
Berthold, F.
Hero, B.
Simon, T.
Schmidt, M.
Decarolis, B.
Eggert, A.
Berthold, F.
Hero, B.
- Publication Year :
- 2017
Details
- Database :
- OAIster
- Notes :
- English
- Publication Type :
- Electronic Resource
- Accession number :
- edsoai.on1201321807
- Document Type :
- Electronic Resource